44.03
price down icon0.18%   -0.08
after-market  Handel nachbörslich:  44.07  0.04   +0.09%
loading

Finanzdaten der Bristol-Myers Squibb Co.-Aktie (BMY)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
4.66%
11,477.00
10,966.00 11,226.00 11,337.00 11,406.00
Cost Of Revenue
9.54%
2,745.00
2,506.00 2,876.00 2,566.00 2,593.00
Gross Profit
3.22%
8,732.00
8,460.00 8,350.00 8,771.00 8,813.00
Operating Expenses
11.62%
7,058.00
6,323.00 6,491.00 6,001.00 6,954.00
Interest Income/Expense
12.86%
316.00
280.00 282.00 288.00 294.00
Benefits Costs and Expenses
11.03%
9,803.00
8,829.00 9,367.00 8,567.00 9,547.00
Costs And Expenses
11.03%
9,803.00
8,829.00 9,367.00 8,567.00 9,547.00
Operating Income/Loss
21.67%
1,674.00
2,137.00 1,859.00 2,770.00 1,859.00
Income/Loss Before Equity Method Investments
19.89%
1,712.00
2,137.00 1,870.00 2,790.00 1,860.00
Income/Loss From Equity Method Investments
238.89%
-25.00
18.00 -11.00 -20.00 -1.00
Income/Loss From Continuing Operations Before Tax
21.67%
1,674.00
2,137.00 1,859.00 2,770.00 1,859.00
Income Tax Expense/Benefit, Deferred
305.81%
-1,327.00
-327.00 -1,086.00 -548.00 -624.00
Income Tax Expense/Benefit
143.35%
-88.00
203.00 -218.00 503.00 -166.00
Income/Loss From Continuing Operations After Tax
8.89%
1,762.00
1,934.00 2,077.00 2,267.00 2,025.00
Net Income/Loss
8.89%
1,762.00
1,934.00 2,077.00 2,267.00 2,025.00
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
100.00%
-
6.00 4.00 5.00 3.00
Basic Average Shares
100.68%
-14.00
2,057.00 2,093.00 2,099.00 -7.00
Diluted Average Shares
100.73%
-15.00
2,064.00 2,102.00 2,113.00 -8.00
Basic Earnings Per Share
7.45%
0.87
0.94 0.99 1.08 0.96
Diluted Earnings Per Share
6.45%
0.87
0.93 0.99 1.07 0.95
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
drug_manufacturers_general GSK
$44.98
price up icon 0.22%
drug_manufacturers_general SNY
$48.67
price down icon 0.31%
drug_manufacturers_general PFE
$28.64
price down icon 0.97%
$312.47
price down icon 0.71%
drug_manufacturers_general NVS
$102.57
price down icon 0.12%
Kapitalisierung:     |  Volumen (24h):